최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한 두경부 종양 학회지 = Korean journal of head & neck oncology, v.31 no.2, 2015년, pp.1 - 5
박영민 (대진의료재단 분당제생병원) , 김세헌 (연세대학교 의과대학 이비인후과학 교실)
The role of transoral robotic surgery in the treatment of upper aerodigestive tract tumor has expanded in recent. Since the approval of the da Vinci system, the number of transoral robotic surgery has increased significantly. The main indications of transoral robotic surgery are tumors of oropharynx...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
두경부 암의 수술적 치료와 관련하여 활발히 연구되고 있는 분야가 경구강 로봇 수술인데, 이것의 장점은 무엇인가? | 이후 여러 기관에서 경구강 로봇 수술의 안정성과 유효성을 보고하였고 기존의 수술과 대등한 종양학적 결과를 보고하였다.7-10) 경구강 로봇 수술은 추가적인 경부 절개 없이 구강을 통하여 진행되기 때문에 수술에 따른 이환율을 최소화 할 수 있는 장점을 가지고 있다. 이는 기존의 전통적인 수술 방법과 비교하여 수술 후 환자의 삶의 질을 월등히 향상시킬 수 있는 요인으로 작용한다. | |
두경부 암의 대표적인 위험인자는 무엇인가? | 음주와 흡연은 두경부 암의 대표적인 위험인자이며, 흡연 인구의 감소에 따라 이와 연관된 두경부 암의 발생 빈도는 감소하고 있다.1-3) 하지만 흡연과는 상관없이 인간 유두종 바이러스 감염과 관련된 두경부 암의 발생은 증가하고 있는 실정이다. | |
악성 종양의 치료를 위해 방사선 치료, 항암 치료가 널리 이용되는 이유는? | 최근에는 구강을 제외한 두경부에 발생한 악성 종양의 치료를 위해 방사선 치료와 항암 치료가 널리 이용되고 있으며, 이는 기존의 전통적인 수술 시행 후 초래될 수 있는 합병증과 높은 이환율 때문이다. 하지만 위에 언급한 바와 같이 두경부 암의 역학적 측면에서 큰 변화가 생기고, 방사선 치료와 연관되어 뒤늦게 초래되는 독성에 대해 관심이 높아지면서 다시 수술적 치료에 대한 관심이 높아지고 있다. |
Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110(7):1429-1435.
Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113):2901-2909.
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, et al. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014;32(35):3930-3938.
Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272(2):463-471.
Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(11): 1079-1085.
Genden EM, Desai S, Sung CK. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2009;31(3):283-289.
Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal EL, Magnuson JS. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2009;141(2):166-171.
Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119(11):2156-2164.
Park YM, Lee JG, Lee WS, Choi EC, Chung SM, Kim SH. Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer. Oral Oncol. 2009;45(8):e62-e66.
Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. Oncological and functional outcomes of transoral robotic surgery for oropharyngeal cancer. Br J Oral Maxillofac Surg. 2013;51(5):408-412.
Lee SY, Park YM, Byeon HK, Choi EC, Kim SH. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck. 2014;36(8):1138-1145.
de Almeida JR, Byrd JK, Wu R, Stucken CL, Duvvuri U, Goldstein DP, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096-2102.
Smith RV, Goldman SY, Beitler JJ, Wadler SS. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(7):831-836.
Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289-1298.
Rancati T, Schwarz M, Allen AM, Feng F, Popovtzer A, Mittal B, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S64-S69.
Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, et al. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg. 2004;130(7):875-879.
Cabanillas R1, Rodrigo JP, Llorente JL, Suarez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2008;30(6):750-755.
Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg. 1998;124(11):1245-1250.
Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis GA, et al. Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope. 2009;119(9):1704-1708.
Mendelsohn AH, Remacle M. Transoral robotic surgery for laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2015;23(2):148-152.
Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V, Lawson G. Outcomes following transoral robotic surgery: supraglottic laryngectomy. Laryngoscope. 2013;123(1):208-214.
Olsen SM, Moore EJ, Koch CA, Price DL, Kasperbauer JL, Olsen KD. Transoral robotic surgery for supraglottic squamous cell carcinoma. Am J Otolaryngol. 2012;33(4):379-384.
Ozer E, Alvarez B, Kakarala K, Durmus K, Teknos TN, Carrau RL. Clinical outcomes of transoral robotic supraglottic laryngectomy. Head Neck. 2013;35(8):1158-1161.
Park YM, Lee WJ, Lee JG, Lee WS, Choi EC, Chung SM, et al. Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A. 2009;19(3):361-368.
Park YM, Kim WS, Byeon HK, De Virgilio A, Jung JS, Kim SH. Feasiblity of transoral robotic hypopharyngectomy for early-stage hypopharyngeal carcinoma. Oral Oncol. 2010;46(8):597-602.
Park YM, Kim WS, De Virgilio A, Lee SY, Seol JH, Kim SH. Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-year oncologic and functional analysis. Oral Oncol. 2012;48(6):560-566.
Park YM, Byeon HK, Chung HP, Choi EC, Kim SH. Comparison study of transoral robotic surgery and radical open surgery for hypopharyngeal cancer. Acta Otolaryngol. 2013;133(6):641-648.
Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. Surgical techniques and treatment outcomes of transoral robotic supraglottic partial laryngectomy. Laryngoscope. 2013;123(3):670-677.
Tateya I, Ishikawa S, Morita S, Ito H, Sakamoto T, Murayama T, et al. Magnifying endoscopy with narrow band imaging to determine the extent of resection in transoral robotic surgery of oropharyngeal cancer. Case Rep Otolaryngol. 2014;2014:604737.
Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal EL, Magnuson JS. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2009;141(2):166-171.
Tateya I, Morita S, Muto M, Miyamoto S, Hayashi T, Funakoshi M, et al. Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope. 2015;125(5):1124-1129.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.